Moorman AV - Search Results

1

Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia.

Allan JM, Wild CP, Rollinson S, Willett EV, Moorman AV, Dovey GJ, Roddam PL, Roman E, Cartwright RA, Morgan GJ. Allan JM, et al. Among authors: moorman av. Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11592-7. doi: 10.1073/pnas.191211198. Epub 2001 Sep 11. Proc Natl Acad Sci U S A. 2001. PMID: 11553769 Free PMC article.

2

Poor metabolizers at the cytochrome P450 2D6 and 2C19 loci are at increased risk of developing adult acute leukaemia.

Roddam PL, Rollinson S, Kane E, Roman E, Moorman A, Cartwright R, Morgan GJ. Roddam PL, et al. Pharmacogenetics. 2000 Oct;10(7):605-15. doi: 10.1097/00008571-200010000-00004. Pharmacogenetics. 2000. PMID: 11037802

3

Karyotype and age in acute myeloid leukemia. Are they linked?

Moorman AV, Roman E, Willett EV, Dovey GJ, Cartwright RA, Morgan GJ. Moorman AV, et al. Cancer Genet Cytogenet. 2001 Apr 15;126(2):155-61. doi: 10.1016/s0165-4608(00)00414-3. Cancer Genet Cytogenet. 2001. PMID: 11376809

4

Incidence of childhood acute lymphoblastic leukaemia in Yorkshire, UK.

Feltbower RG, Moorman AV, Dovey G, Kinsey SE, McKinney PA. Feltbower RG, et al. Among authors: moorman av. Lancet. 2001 Aug 4;358(9279):385-7. doi: 10.1016/S0140-6736(01)05581-7. Lancet. 2001. PMID: 11502322

5

Genetic polymorphisms in microsomal epoxide hydrolase and susceptibility to adult acute myeloid leukaemia with defined cytogenetic abnormalities.

Lebailly P, Willett EV, Moorman AV, Roman E, Cartwright R, Morgan GJ, Wild CP. Lebailly P, et al. Among authors: moorman av. Br J Haematol. 2002 Mar;116(3):587-94. doi: 10.1046/j.0007-1048.2001.03320.x. Br J Haematol. 2002. PMID: 11849215

6

Smoking and the risk of acute myeloid leukaemia in cytogenetic subgroups.

Moorman AV, Roman E, Cartwright RA, Morgan GJ. Moorman AV, et al. Br J Cancer. 2002 Jan 7;86(1):60-2. doi: 10.1038/sj.bjc.6600010. Br J Cancer. 2002. PMID: 11857012 Free PMC article.

7

Age-specific incidence rates for cytogenetically-defined subtypes of acute myeloid leukaemia.

Moorman AV, Roman E, Cartwright RA, Morgan GJ. Moorman AV, et al. Br J Cancer. 2002 Apr 8;86(7):1061-3. doi: 10.1038/sj.bjc.6600195. Br J Cancer. 2002. PMID: 11953849 Free PMC article.

8

Patients entered into MRC AML trials are biologically representative of the totality of the disease in the UK.

Moorman AV, Roman E, Cartwright RA, Morgan GJ. Moorman AV, et al. Clin Lab Haematol. 2002 Aug;24(4):263-5. doi: 10.1046/j.1365-2257.2002.00445.x. Clin Lab Haematol. 2002. PMID: 12181033 No abstract available.

9

Sex ratios and the risks of haematological malignancies.

Cartwright RA, Gurney KA, Moorman AV. Cartwright RA, et al. Among authors: moorman av. Br J Haematol. 2002 Sep;118(4):1071-7. doi: 10.1046/j.1365-2141.2002.03750.x. Br J Haematol. 2002. PMID: 12199787

10

Population-based demographic study of karyotypes in 1709 patients with adult acute myeloid leukemia.

Sanderson RN, Johnson PR, Moorman AV, Roman E, Willett E, Taylor PR, Proctor SJ, Bown N, Ogston S, Bowen DT. Sanderson RN, et al. Among authors: moorman av. Leukemia. 2006 Mar;20(3):444-50. doi: 10.1038/sj.leu.2404055. Leukemia. 2006. PMID: 16424877

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters